We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
3376
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$2.56M ﹤0.01%
27,641
-213
-0.8% -$18K
CKPT
3377
DELISTED
Checkpoint Therapeutics
CKPT
$2.55M ﹤0.01%
148,188
+26,704
+22% +$447K
ORGS
3378
DELISTED
Orgenesis Inc. Common Stock
ORGS
$2.55M ﹤0.01%
54,652
ICBK
3379
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$2.54M ﹤0.01%
99,287
+3,875
+4% +$89.9K
SNFCA icon
3380
Security National Financial
SNFCA
$251M
$2.53M ﹤0.01%
624,459
-31,707
-5% -$116K
PFSW
3381
DELISTED
PFSweb, Inc.
PFSW
$2.52M ﹤0.01%
660,802
+16,200
+3% +$55K
SCYX icon
3382
SCYNEXIS
SCYX
$51.6M
$2.52M ﹤0.01%
34,646
+2,395
+7% +$198K
SHLO
3383
DELISTED
Shiloh Industries Inc
SHLO
$2.52M ﹤0.01%
706,892
SND icon
3384
Smart Sand
SND
$190M
$2.51M ﹤0.01%
996,786
-929
-0.1% -$2.3K
CBUS icon
3385
Cibus
CBUS
$143M
$2.5M ﹤0.01%
7,137
+33
+0.5% +$8.28K
ATXS
3386
DELISTED
Astria Therapeutics
ATXS
$2.49M ﹤0.01%
70,302
ELMD icon
3387
Electromed
ELMD
$348M
$2.48M ﹤0.01%
286,578
+3,550
+1% +$28.1K
TEUM
3388
DELISTED
Pareteum Corporation
TEUM
$2.47M ﹤0.01%
5,648,941
+320,223
+6% +$185K
YARW
3389
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$2.46M ﹤0.01%
147
-1
-0.7% -$16.7K
KDNY
3390
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.46M ﹤0.01%
416,958
-29,057
-7% -$158K
HNRG icon
3391
Hallador Energy
HNRG
$698M
$2.46M ﹤0.01%
826,555
-854
-0.1% -$2.62K
GWGH
3392
DELISTED
GWG Holdings, Inc
GWGH
$2.45M ﹤0.01%
249,833
+5,223
+2% +$51.4K
RMCF icon
3393
Rocky Mountain Chocolate Factory
RMCF
$7.93M
$2.44M ﹤0.01%
264,600
+56
+0% +$501
RELL icon
3394
Richardson Electronics
RELL
$305M
$2.44M ﹤0.01%
433,345
ACU icon
3395
Acme United Corp
ACU
$214M
$2.44M ﹤0.01%
102,351
ETNB
3396
DELISTED
89bio
ETNB
$2.43M ﹤0.01%
+92,477
New +$2.57M
IMH
3397
DELISTED
Impac Mortgage Holdings Inc.
IMH
$2.4M ﹤0.01%
455,842
+32,723
+8% +$213K
CTIC
3398
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.4M ﹤0.01%
1,515,674
+178,869
+13% +$169K
AVNW icon
3399
Aviat Networks
AVNW
$272M
$2.39M ﹤0.01%
340,216
MBRX icon
3400
Moleculin Biotech
MBRX
$2.72M
$2.38M ﹤0.01%
1,156
-1
-0.1% -$2.34K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.